Press release
CD Bioparticles Launches Additive Powders to Drive Innovation in 3D Printing and Advanced Manufacturing
CD Bioparticles announces a comprehensive range of Additive Powders for various applications.With years of experience in the pharmaceutical and life science sectors, CD Bioparticles has announced the expansion of its product portfolio with a comprehensive range of Additive Powders [https://www.cd-bioparticles.com/products/additive-powders-1969.html], to meet the rigorous demands of researchers and industrial manufacturers in additive manufacturing (3D printing), surface coatings, advanced materials development, and biomedical applications.
Additive powders are finely particulate materials used to enhance or modify the properties of a substrate and are widely used across numerous industries. They can improve a material's mechanical and chemical properties, such as strength, durability, conductivity and heat resistance. In addition, they play a crucial role in fields including additive manufacturing, coatings, polymer processing, and composite materials.
To support the research needs, CD Bioparticles now offers a diverse range of additive powders for scientists and engineers, including alloy, compound, and elemental powders. These new products can be utilized by researchers in various fields, including 3D printing, surface coatings, metal injection moulding (MIM), powder metallurgy, composites (such as metal matrix composites and polymer composites), energy storage and batteries, and biomedical applications (such as orthopaedic and dental implants).
For example, CD Bioparticles now supplies alloy powders that are specifically designed for 3D printing and additive manufacturing. These powders are characterized by high purity, high sphericity, and diverse particle size distributions. Additionally, custom particle sizes are available for high-entropy alloy powders for advanced manufacturing applications. Alloy powders are finely processed mixtures of metallic elements, often engineered to enhance properties such as strength, corrosion resistance, or thermal stability. They primarily encompass iron-, nickel-, and cobalt-based alloy materials and are used extensively in powder metallurgy, additive manufacturing, and surface coating processes.
In addition, CD Bioparticles offers boride powders, multi-element oxide powders and single-element oxide powders in various particle sizes for different applications. Nanoscale and micron-scale powders are also available upon request. Compound powders can be formulated through multiple methods and are characterized by their ability to combine the advantages of their constituent elements in order to achieve specific physical, chemical or functional properties.
CD Bioparticles also supplies generic metallic, non-metallic and rare earth element powders, all of which are available with customizable particle size specifications. These powders are suitable for a variety of applications, including additive manufacturing, metallurgy, chemical reactions, pharmaceuticals, and electronics. Elemental powders consist of a single element and are primarily used in scientific research, manufacturing, materials science, chemistry, pharmaceuticals and other specialized fields. They are categorized as either non-metallic or metallic, with the latter being further subdivided into rare earth and general metallic powders.
CD Bioparticles' expanded portfolio provides scientists and engineers with the high-purity materials they need for research applications. To know more information about the new offerings, or to contact the CD Bioparticles team for a consultation, quote, or proposal, please visit https://www.cd-bioparticles.com/products/additive-powders-1969.html.
About CD Bioparticles
CD Bioparticles is a leading manufacturer and supplier of various nanoparticles, microparticles, and coatings for R&D as well as commercialization across different application areas, including in vitro diagnostics, biochemistry, cellular analysis, cell separation, and immunoassay. The company also offers various custom services, including chemical surface-functionalization, fluorescent modification, antibody immobilization, as well as nucleic acid and oligo conjugation to meet client specifications.
Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cd-bioparticles-launches-additive-powders-to-drive-innovation-in-3d-printing-and-advanced-manufacturing]
Country: United States
Website: https://www.cd-bioparticles.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD Bioparticles Launches Additive Powders to Drive Innovation in 3D Printing and Advanced Manufacturing here
News-ID: 4315607 • Views: …
More Releases from ABNewswire
Bronchiectasis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveI …
The Key Bronchiectasis Companies in the market include - Insmed, Zambon, Chiesi Farmaceutici, Sanofi, Boehringer Ingelheim, Gilead Sciences, Syntara, and others.
DelveInsight's "Bronchiectasis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Bronchiectasis, historical and forecasted epidemiology as well as the Bronchiectasis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of…
TrishaHitches.com Launches to Help Brands Access Clean, Platform-Ready UGC Conte …
The launch of TrishaHitches.com [trishahitches.com] marks a key milestone for brands seeking authentic, high-converting UGC content. The new content hub gives businesses a simple way to send their product and receive clean, platform-ready videos and photos designed to blend naturally into social feeds and drive action.
This streamlined process makes it easier for brands to scale their content needs without relying on influencers, complicated posting agreements, or expensive studio production.
Filling a…
"Dante's London Bridge" by Peter Prizel Delivers a Haunting Blend of Time Travel …
Dante's London Bridge by Peter Prizel is a haunting, genre-blending novel of time travel, historical mystery, and spiritual redemption. When a young scholar uncovers a forgotten manuscript beneath London Bridge, messages, letters, telegrams, poetry, and emails, begin to transcend time and the afterlife. Rich in gothic symbolism and emotional depth, the novel explores guilt, forgiveness, and redemption, with cinematic appeal for major retail and screen adaptation.
Los Angeles, CA - December…
Maple and Mocha Coffee's Holiday Campaign Brings Clean Water to Kirinda Village …
Emerging specialty roaster Maple and Mocha Coffee reports strong holiday season response to its Vermont Maple Pecan blend and clean water initiative. The company's commitment to donating 10% of sales to the Kyempapu Water Project resonates with gift-buyers seeking purpose-driven purchases during the festive season.
The intersection of holiday traditions and social responsibility has found a sweet spot in Maple and Mocha Coffee's Vermont Maple Pecan blend, as conscious consumers embrace…
More Releases for Bioparticles
CD Bioparticles Strengthens Drug Development Pipeline with Comprehensive Animal …
CD Bioparticles launches Animal Models Evaluation services to accelerate the clinical translation and registration of novel therapeutics.
New York, USA - November 24, 2025 - CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its comprehensive Animal Models Evaluation [https://www.cd-bioparticles.net/services/bioparticles-analysiscand-characterization/animal-models-evaluation] services to accelerate the clinical translation and registration of novel therapeutics, by providing essential in vivo data under both Non-GLP and…
CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Parti …
CD Bioparticles announces its advanced line of multiplex fluorescence particles.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces its advanced line of multiplex fluorescence particles [https://www.cd-bioparticles.com/products/multiplex-assays-466.html] designed to streamline complex biological assays in flow cytometry experiments. These particles exhibit low signal widths in the forward scatter, side scatter and fluorescence channels. Various surface modifications, channels and sizes are also supported.
Flow cytometry is a convenient detection…
CD Bioparticles Announces Offering of Polystyrene Family Polymers for Drug Deliv …
CD Bioparticles announces the availability of Polystyrene Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is pleased to announce the availability of Polystyrene Family polymers [https://www.cd-bioparticles.net/polystyrene-family] for a variety of drug delivery applications. These polymers offer tunable physicochemical properties that enable sustained release profiles and improved drug bioavailability.
The polystyrene family, a group of polymers derived from…
CD Bioparticles Introduces New Polyolefin Family Polymers for Drug Delivery Appl …
CD Bioparticles announces Polyolefin Family polymers for a variety of drug delivery applications.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has recently expanded its low PDI polymer portfolio and announces its new offering of Polyolefin Family [https://www.cd-bioparticles.net/polyolefin-family] polymers with a wide range of properties that make them well-suited for a variety of drug delivery applications.
Low dispersion index polymers are polymeric compounds with low molecular…
CD Bioparticles Introduces the Launch of Organic Gold Nanoparticles
With years of experience in the pharmaceutical and life science sector, CD Bioparticles now launches a comprehensive list of organic gold nanoparticles for research applications. These organic gold nanoparticles have a hydrophobic surface character and have great solubility in a wide range of organic solvents.
CD Bioparticles offers a comprehensive list of coatings, functional and conjugated gold nanoparticles through precise surface engineering. It offers gold nanoparticles functionalized with reactive groups such…
CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers
As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.
With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the…
